Neural toxicity of retroviruses

Neuroscience Letters

Volumn 220, Issue 1, 1996, Pages 66-68

  Hurley, Michael J ^a   Bradford, Henry F ^a   O'Hare, Kevin ^a   Stern, Gerald M ^b   Uchida, Kohichi ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cell culture; cerebral cortex; rat; retrovirus; tyrosine hydroxylase; ventral mesencephalon

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL CULTURE; CONTROLLED STUDY; FETUS; GLIA CELL; MESENCEPHALON; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; VIRUS INFECTION;

ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEXADIMETHRINE; LAC OPERON; MESENCEPHALON; RATS; RETROVIRIDAE; TYROSINE 3-MONOOXYGENASE;

EID: 0030572990     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13224-9     Document Type: Article

References (11)

1. [1] Byrnes, A.P., Rushby, J.E., Wood, M.J.A. and Charlton, H.M., Adenovirus gene transfer causes inflammation in the brain, Neuroscience, 66 (1995) 1015-1024.
2. [2] Horellou, P., Brundin, P., Kalén, P., Mallet, J. and Bjorklund, A., In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum, Neuron, 5 (1990) 393-402.
3. [3] Horellou, P., Guibert, B., Leviel, V. and Mallet, J., Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells, Proc. Natl. Acad. Sci. USA, 86 (1989) 7233-7237.
4. [4] Hornykiewicz, O., Parkinson's disease: from brain homogenate to treatment, Fed. Proc., 32 (1973) 183-190.
5. [5] Kawaja, M.D., Fisher, L.J., Shinstine, S., Jinnah, H.A., Ray, J., Chen, L.S. and Gage, F.H., Grafting genetically modified cells within the rat central nervous system: methodological considerations. In S.B. Dunnett and A. Björklund (Eds.), Neural Transplantation A Practical Approach, IRL Press, Oxford, 1992.
6. [6] Sabaté, O., Horellou, P., Vigne, E., Colin, P., Perricaudet, M., Buc-Caron, M.-H. and Mallet, J., Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses, Nature Gen., 9 (1995) 256-260.
7. [7] Stoker, A.W., Retroviral vectors. In A.J. Davison and R.M. Elliot (Eds.), Molecular Virology A Practical Approach, IRL Press, Cambridge, 1993.
8. [8] Uchida, K., Tsuzaki, N., Nagatsu, T. and Kohsaka, S., Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopa-minetreated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA, Dev. Neurosci., 14 (1992) 173-180.
9. [9] Walters, A.M., Clarke, D.J., Bradford, H.F. and Stern, G.M., The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the parkinsonian syndrome. Neurochem. Res., 17 (1992) 893-900.
10. [10] Wolff, J.A., Fisher, L.J., Xu, L., Jinnah, H.A., Langlais, P.J., Iuvone, P.M., O'Malley, K.L., Rosenburg, M.B., Shimohama, S., Friedman, T. and Gage, F.H., Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 9011-9014.
11. [11] Zhou, J., Bradford, H.F. and Stern, G.M., The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment, Brain Res., 656 (1994) 147-156.